FDA Takes Aim At Unapproved Cough Drugs
The U.S. Food and Drug Administration said Friday it will take action against companies that market unapproved drug products in timed-release dosage form that contain guaifenesin, a substance commonly used in...To view the full article, register now.
Already a subscriber? Click here to view full article